Since Cpt1c can protect cancer cells from stress-mediated death and contribute to PTC development and progression, the application of Cpt1c inhibitors (alone and in combination with AMPK agonists) could be used as a new promising way in PTC treatment [41]. Here, CPT1C is linked to cancer.